Dr. Mayock’s basic research interests include evaluation of the effects of fetal and neonatal drug (alcohol, morphine) exposure on fetal, neonatal and adult cerebrovascular function. Dr. Mayock’s clinical research interests include evaluation of therapies that potentially may alter the development of Bronchopulmonary Dysplasia such as inhaled nitric oxide and late surfactant treatments. In collaboration with Drs. Juul and Gleason, he is evaluating whether high dose erythropoietin treatment has neuroprotective effects in preterm and term infants.

1. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE for the NO CLD Study Group. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. New Eng J Med, 355:343-353, 2006.
2. Mayock DE, Bennett R, Robinson RD, Gleason CA: Dopamine does not limit fetal cerebrovascular responses to hypoxia. J App Physiol 102:130-134,
3. Konduri GG, Vohr B, Robertson C, Sokol GM, Solimano A, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork, E, Kirpalani H, Peliowski A, Johnson Y, for the Neonatal Inhaled Nitric Oxide Study Group (Mayock DE - Site Investigator): Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr 150:235-240, 2007.
4. Di Flore JM, Hibbs AM, Zadell AE, Merrill JD, Eichenwald EC, Puri AR, Mayock DE, Courtney SE, Ballard RA, Martin RJ: The effect of inhaled nitric oxide on pulmonary function in preterm infants. J Perinatol 27:766-771, 2007.
5. Mayock DE, Ngai AC, Mondares RL, Gleason CA: Effects of binge alcohol exposure in the second trimester on intracerebral arteriolar function in third trimester fetal sheep. Brain Research 1226:111-115, 2008.